Genetic markers in CYP2C19 and CYP2B6 for prediction of cyclophosphamide's 4-hydroxylation, efficacy and side effects in Chinese patients with systemic lupus erythematosus.
about
Monocyte chemoattractant protein-1 (MCP-1)-2518 A/G polymorphism and lupus nephritis risk: A PRISMA-compliant meta-analysis.Epistatic interactions among CYP2C19*2, CYP3A4 and GSTP1 on the cyclophosphamide therapy in lupus nephritis patients.Cytochrome P450 Genetic Variations Can Predict mRNA Expression, Cyclophosphamide 4-Hydroxylation, and Treatment Outcomes in Chinese Patients With Non-Hodgkin's Lymphoma.
P2860
Genetic markers in CYP2C19 and CYP2B6 for prediction of cyclophosphamide's 4-hydroxylation, efficacy and side effects in Chinese patients with systemic lupus erythematosus.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Genetic markers in CYP2C19 and ...... systemic lupus erythematosus.
@ast
Genetic markers in CYP2C19 and ...... systemic lupus erythematosus.
@en
type
label
Genetic markers in CYP2C19 and ...... systemic lupus erythematosus.
@ast
Genetic markers in CYP2C19 and ...... systemic lupus erythematosus.
@en
prefLabel
Genetic markers in CYP2C19 and ...... systemic lupus erythematosus.
@ast
Genetic markers in CYP2C19 and ...... systemic lupus erythematosus.
@en
P2093
P2860
P356
P1476
Genetic markers in CYP2C19 and ...... systemic lupus erythematosus.
@en
P2093
Lingyan Chen
Liuqin Liang
Wenying Shu
Xiuyan Yang
Xueding Wang
Zhuojia Chen
P2860
P304
P356
10.1111/BCP.12800
P407
P577
2015-10-11T00:00:00Z